|
| 37224883 | Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study. | | 2023 |
| 37609698 | Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: The Switching Antiplatelet-6 (SWAP-6) Study. | | 2023 |
| 36602868 | Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study. | | 2023 |
| 34983074 | Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease. | Thrombosis and Haemostasis | 2022 |
| 36048358 | Impact of diabetes mellitus on the pharmacodynamic effects of prasugrel and ticagrelor after switching from clopidogrel in patients with coronary artery disease. | Journal of Thrombosis and Thrombolysis | 2022 |
| 36036856 | Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study. | J Thromb Thrombolysis | 2022 |
| 35353154 | Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy. | European Heart Journal - Cardiovascular Pharmacotherapy | 2022 |
| 34114623 | Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery disease. | European Heart Journal - Cardiovascular Pharmacotherapy | 2022 |
| 34736741 | Impact of Timing of Pharmacodynamic Assessment on Platelet Reactivity in Patients Treated With Cangrelor. | JACC: Cardiovascular Interventions | 2021 |
| 33637605 | Effects of D-allulose on glucose tolerance and insulin response to a standard oral sucrose load: results of a prospective, randomized, crossover study. | BMJ Open Diabetes Research and Care | 2021 |
| 33582955 | Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor. | Journal of Thrombosis and Thrombolysis | 2021 |
| 31470444 | Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study. | Thrombosis and Haemostasis | 2020 |
| 32306797 | Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y Receptor Inhibitors With and Without Aspirin: Results of the VORA-PRATIC Study. | Journal of the American Heart Association | 2020 |
| 32478205 | Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes: Results of a Randomized Pharmacodynamic Study in a Feasibility Investigation of Rapid Genetic Testing. | JACC: Basic to Translational Science | 2020 |
| 33044856 | Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: Th | Circulation | 2020 |
| 31377269 | Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With Morphine. | JACC: Cardiovascular Interventions | 2019 |
| 31998847 | Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study. | JACC: Basic to Translational Science | 2019 |
| 30630341 | Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. | Circulation | 2019 |
| 29642909 | Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention. | J Transl Med | 2018 |
| 29526833 | Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP-4 Study. | Circulation | 2018 |
| 28683943 | In Vitro Pharmacodynamic Effects of Cangrelor on Platelet P2Y Receptor-Mediated Signaling in Ticagrelor-Treated Patients. | JACC: Cardiovascular Interventions | 2017 |
| 27559041 | Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study. | Circulation | 2016 |
| 27013060 | Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor: Results of the Prospective, Randomized SWAP-3 Study. | JACC: Cardiovascular Interventions | 2016 |
| 24509480 | Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. | Nat Genet | 2014 |
| 23617586 | Carriers of a novel frame-shift insertion in WNT16a possess elevated pancreatic expression of TCF7L2. | BMC Genetics | 2013 |
| 24097068 | Discovery and refinement of loci associated with lipid levels. | Nat Genet | 2013 |
| 24097064 | Common variants associated with plasma triglycerides and risk for coronary artery disease. | Nat Genet | 2013 |
| 23300278 | Genome-wide association study identifies a novel locus contributing to type 2 diabetes susceptibility in Sikhs of Punjabi origin from India. | Diabetes | 2013 |
| 22109280 | Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. | Diabetologia | 2012 |
| 22623978 | A replication study of GWAS-derived lipid genes in Asian Indians: the chromosomal region 11q23.3 harbors loci contributing to triglycerides. | PLoS One | 2012 |
| 24199029 | Vitamin D Deficiency and Cardio-Metabolic Risk in a North Indian Community with Highly Prevalent Type 2 Diabetes. | | 2012 |
| 21558052 | A low frequency variant within the GWAS locus of MTNR1B affects fasting glucose concentrations: genetic risk is modulated by obesity. | Nutr Metab Cardiovasc Dis | 2012 |
| 22143414 | Genetic variation in cholesterol ester transfer protein, serum CETP activity, and coronary artery disease risk in Asian Indian diabetic cohort. | Pharmacogenetics and Genomics | 2012 |
| 21698157 | Genome-wide linkage scan to identify loci associated with type 2 diabetes and blood lipid phenotypes in the Sikh Diabetes Study. | PLoS ONE | 2011 |
| 21261977 | Variants in KCNQ1 increase type II diabetes susceptibility in South Asians: a study of 3,310 subjects from India and the US. | BMC Med Genet | 2011 |
| 21874001 | Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. | Nat Genet | 2011 |
| 19846176 | PPARG and ADIPOQ gene polymorphisms increase type 2 diabetes mellitus risk in Asian Indian Sikhs: Pro12Ala still remains as the strongest predictor. | Metabolism | 2010 |
| 19680233 | Replication of association between a common variant near melanocortin-4 receptor gene and obesity-related traits in Asian Sikhs. | Obesity (Silver Spring) | 2010 |
| 19247373 | Testing the association of novel meta-analysis-derived diabetes risk genes with type II diabetes and related metabolic traits in Asian Indian Sikhs. | J Hum Genet | 2009 |